An annual conference is held in Washington, D.C., as part of Global Asbestos Awareness Week, featuring medical professionals, survivors and advocates sharing about advancements and personal struggles. For 10 years, more than 70 speakers and honorees have participated in the three-day event. Many are honored for their dedication to advancing[…]
Full Archive
Asbestos organization fights to ban the fibrous carcinogen
Ten years ago, the Asbestos Disease Awareness Organization (ADAO) expanded their reach by making the first week of April National Asbestos Awareness Week. Soon after, other countries suffering from the carcinogen’s deadly effects joined and transformed the week into a global occasion. The ADAO started in 2004 to provide a[…]
New research suggests earlier mesothelioma diagnosis is a possibility
Those familiar with the asbestos-caused cancer mesothelioma are well aware the disease takes decades to develop and by the time it’s recognized, it’s too late for recovery. When symptoms finally develop and mesothelioma is diagnosed, its victims often survive less than one year. In 2008, Japanese researchers released a study[…]
Asbestos Disease Awareness Organization celebrates tenth annual week
Ten years ago, the Asbestos Disease Awareness Organization (ADAO) expanded their reach by making the first week of April National Asbestos Awareness Week. Soon after, other countries suffering from the carcinogen’s deadly effects joined and transformed the week into a global occasion. The ADAO started in 2004 to provide a[…]
New study suggests breast cancer drug may shrink mesothelioma tumors
After new evidence surfaced suggesting the enzyme aromatase is associated with malignant mesothelioma, Italian scientists began testing breast cancer drug Aromasin (exemestane) on mice and mesothelioma cells. Designed to inhibit aromatase, Aromasin curbs cell growth in breast cancer patients by helping reduce the amount of estrogen in the body. In[…]
Alimta remains best treatment for victims of malignant pleural mesothelioma
For those with inoperable malignant pleural mesothelioma, Alimta (permetrexed) combined with cisplatin remains the top treatment. Japanese researchers recently analyzed the results of 30 patients taking either Gemzar or the Alimta combination and compared complications, disease control and survival rates. Thirty mesothelioma cases were examined featuring 13 patients taking Gemzar[…]
Research shows both mesothelioma surgeries produce results
A recent study by United Kingdom researchers discovered when considering the mesothelioma surgery options, there is no clear choice. Cancer centers and mesothelioma doctors often disagree about which procedure to offer between extrapleural pneumonectomy (EPP) and pleurectomy/decotication (P/D). The surgeries attempt to either remove and cure the patient or relieve[…]
New treatment may inhibit the growth of mesothelioma cells
A recent study suggests CARP-1 Functional Mimetics (CFMs) initiated mesothelioma cell death while prohibiting their migration into new colonies. The concept is to mimic the Cell Cycle and Regulatory Protein (CARP) 1 with its ability to assist with apoptosis, or programmed cell death. When new cells become too abundant and[…]